| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
9.762 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
MYBBP1A |
MYBBP1A, P160: Myb-binding protein 1A |
9.762 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CASP8 |
IPI00305242 |
9.762 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
ARFGAP1 |
IPI00175169 |
9.762 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
F5 |
F5: Coagulation factor V precursor |
9.762 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
H2AFX |
H2AFX, H2AX: Histone H2A.x |
9.762 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
9.762 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MARK2 |
IPI00718858 |
9.762 |
Evidence |
|
| FGA |
IPI00021885 |
ALB |
ALB: Uncharacterized protein ALB |
9.762 |
Evidence |
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
PTMA |
IPI00015550 |
9.762 |
Evidence |
|
| MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
TOP2B |
IPI00217709 |
9.762 |
Evidence |
|
| CFLAR |
CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
9.762 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
9.762 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
TOP2B |
IPI00217709 |
9.762 |
Evidence |
|
| COPE |
COPE: Coatomer subunit epsilon |
ARFGAP1 |
IPI00175169 |
9.762 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
DDX46 |
DDX46, KIAA0801: Probable ATP-dependent RNA helicase DDX46 |
9.762 |
Evidence |
|
| CSPG6 |
SMC3, BAM, BMH, CSPG6, SMC3L1: Structural maintenance of chromosomes protein 3 |
TRAFD1 |
TRAFD1, FLN29: TRAF-type zinc finger domain-containing protein 1 |
9.735 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
9.735 |
Evidence |
|
| MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
9.735 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
VCPIP1 |
VCPIP1, KIAA1850, VCIP135: Deubiquitinating protein VCIP135 |
9.735 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
9.735 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
MAPK7 |
mitogen-activated protein kinase 7 isoform 1 |
9.735 |
Evidence |
|
| CEACAM6 |
CEACAM6, NCA: Carcinoembryonic antigen-related cell adhesion molecule 6 precurso |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
9.735 |
Evidence |
|
| S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
DSTN |
DSTN, ACTDP, DSN: Destrin |
9.735 |
Evidence |
|
| PRKR |
EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki |
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
9.735 |
Evidence |
|